HydrochlorothiazideThird Party Manufacturing in India

Hydrochlorothiazide works by inhibiting the sodium-chloride symporter in the distal convoluted tubule of the nephron. This blocks the reabsorption of sodium and chloride ions, leading to increased excretion of water and electrolytes through urine. The reduction in plasma volume initially lowers blood pressure, but the sustained antihypertensive effect also results from reduced peripheral vascular resistance over long-term use. By decreasing the total sodium content of the body, it also causes mild vasodilation. Unlike loop diuretics which act on the ascending limb of the loop of Henle, thiazide diuretics like hydrochlorothiazide have a more moderate diuretic effect but are highly effective for managing mild to moderate hypertension. They are also useful in reducing edema associated with heart failure, hepatic cirrhosis, and renal conditions. Hydrochlorothiazide is one of the most extensively studied antihypertensives and remains a first-line treatment option globally.

Therapeutic Uses

Hydrochlorothiazide is prescribed for the treatment of:

• Hypertension: First-line treatment for mild to moderate hypertension, used alone or in combination with ACE inhibitors, ARBs, or beta-blockers.
• Edema: Manages fluid retention associated with congestive heart failure, hepatic cirrhosis, and corticosteroid therapy.
• Nephrogenic Diabetes Insipidus: Used off-label to reduce urine output in this condition by creating mild volume depletion.

Why Manufacturers Choose Hydrochlorothiazide

Hydrochlorothiazide is one of the most widely prescribed thiazide diuretics globally, making it a high-volume molecule for Indian pharma manufacturers. Its extensive use in fixed-dose combinations with nearly every major antihypertensive class including ARBs and ACE inhibitors creates significant opportunities for PCD franchise partners and export-oriented companies. The molecule is cost-effective, well-tolerated, and has a predictable stability profile for tablet formulation.